MIR8053

Across TCGA pan-cancer cohorts, MIR8053 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR8053 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR8053 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR8053 expression acts as an unfavorable survival marker.

KIRC, THYM, and THCA are the cancer types where MIR8053 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.167	0.605	<.001	126	view →
THYM	OS	Tertile	III,IV	0.103	0.944	<.001	63	view →
THCA	DFS	Tertile	All	0.063	0.811	<.001	54	view →
LIHC	DFS	Tertile	III,IV	0.073	0.364	<.001	54	view →
STAD	DFS	Tertile	All	0.250	0.723	<.001	45	view →
COAD	OS	Tertile	All	0.248	0.577	.005	24	view →
LGG	DFS	Tertile	All	0.148	0.457	.002	18	view →
SKCM	DFS	Tertile	IV	0.134	0.589	.031	9	view →
KIRP	OS	Tertile	All	0.792	0.953	.011	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR8053–KIRC (DFS)

Open the KIRC breakdown →